Aromatase inhibitors better than tamoxifen at reducing the risk of breast cancer recurrence in women
A new study has shown that giving aromatase inhibitors instead of tamoxifen to premenopausal women with estrogen receptor positive (hormone-sensitive) breast cancer significantly reduces the risk of breast cancer recurrence. ...
Feb 3, 2022
0
67